第一作者单位：[1]Beijing Univ Chinese Med, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Xin,Qi Zhirong,Tan Huangying.A Pilot Phase 2 Study of S-1 and Temozolomide as Second-Line Treatment in Patients With Advanced or Metastatic Neuroendocrine Carcinoma[J].PANCREAS.2020,49(3):490-490.
APA：
Wang, Xin,Qi, Zhirong&Tan, Huangying.(2020).A Pilot Phase 2 Study of S-1 and Temozolomide as Second-Line Treatment in Patients With Advanced or Metastatic Neuroendocrine Carcinoma.PANCREAS,49,(3)
MLA：
Wang, Xin,et al."A Pilot Phase 2 Study of S-1 and Temozolomide as Second-Line Treatment in Patients With Advanced or Metastatic Neuroendocrine Carcinoma".PANCREAS 49..3(2020):490-490
